Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2 release.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page displays a government funding notice about potential delays and the NIH Clinical Center's status. The revision history shows an update from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedUI text updates include Show glossary and Hide glossary options, along with minor capitalization tweaks in labels (e.g., Met QC Criteria vs met QC Criteria and Data vs data). The revision note shows the version bump from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedNew revision label added: Revision: v3.3.4 replaces v3.3.3, representing a minor UI update that does not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations section now lists Texas (Houston, MD Anderson Cancer Center). Page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.